Mmu_circ_0005373 and hsa_circ_0136255 participate in the pulmonary fibrosis of systemic sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mmu_circ_0005373 and hsa_circ_0136255 participate in the pulmonary fibrosis of systemic sclerosis

Published:2024-09 Issue: Volume:139 Page:112690
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Sun Xiaolin,Wang Baoyue,Ding Lili,Ding Tiantian,Wang Yongfu^ORCID,Xu Mingguo

Publisher

Elsevier BV

Reference35 articles.

1. Interstitial lung disease in patients with systemic sclerosis: toward personalized-medicine-based prediction and drug screening models of systemic sclerosis-related interstitial lung disease (SSc-ILD);Khedoe;Front. Immunol.,2020

2. Autophagy in pulmonary fibrosis: friend or foe?;Hill;Genes Diseases,2022

3. Expression of 4E-BP1 in juvenile mice alleviates mTOR-induced neuronal dysfunction and epilepsy;Nguyen;Brain,2022

4. Mechanistic target of rapamycin complex 1 (mTORC1) and mTORC2 as key signaling intermediates in mesenchymal cell activation;Walker;J. Biol. Chem.,2016

5. Rapamycin reduces podocyte apoptosis and is involved in autophagy and mTOR/ P70S6K/4EBP1 signaling;Jin;Cell. Physiol. Biochem.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3